These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Cerebrovascular insufficiency in the aged: therapeutic action of piribedil. Controlled clinical study]. De Nicola P. Minerva Med; 1976 May 26; 67(26):1736-9. PubMed ID: 778672 [No Abstract] [Full Text] [Related]
3. [Controlled trial of piribedil (ET 495) in cerebral vascular diseases]. Antonini FM, Baroni A, Marcon G. Minerva Med; 1976 May 26; 67(26):1740-4. PubMed ID: 778673 [No Abstract] [Full Text] [Related]
6. [The treatment of cerebral insufficiency in older humans. Random comparative test with Trivastal]. Varkonyi-Wallerstein P, Licht B, Kronenwerth D. Ther Ggw; 1976 Feb 26; 115(2):265-80. PubMed ID: 769237 [No Abstract] [Full Text] [Related]
12. [Long-term medical treatment of acute cerebrovascular disease sequelae (comparison papaverine-piribedil]. Piccinelli A, Neri G, Agnoli A. Minerva Med; 1974 Nov 10; 65(80):4199-213. PubMed ID: 4610451 [No Abstract] [Full Text] [Related]
13. [Piribedil in the treatment of Parkinson disease (author's transl)]. Nardini M, Sciannandrone R, Fieschi C, De Simone G. Riv Patol Nerv Ment; 1975 Nov 10; 96(2):103-10. PubMed ID: 778998 [Abstract] [Full Text] [Related]
14. Action of piribedil in Parkinson's disease: I.V. test and oral treatment. Emile J, Chanelet J, Truelle JL, Bastard J. Adv Neurol; 1975 Nov 10; 9():409-13. PubMed ID: 1096577 [No Abstract] [Full Text] [Related]
15. Indications of piribedil in L-DOPA-treated parkinsonian patients: physiopathologic implications. Rondot P, Bathien N, Dumas JL. Adv Neurol; 1975 Nov 10; 9():373-81. PubMed ID: 1096574 [No Abstract] [Full Text] [Related]